Rakesh Narang

556 total citations
25 papers, 376 citations indexed

About

Rakesh Narang is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Rakesh Narang has authored 25 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Rakesh Narang's work include Synthesis and biological activity (11 papers), Click Chemistry and Applications (4 papers) and Computational Drug Discovery Methods (4 papers). Rakesh Narang is often cited by papers focused on Synthesis and biological activity (11 papers), Click Chemistry and Applications (4 papers) and Computational Drug Discovery Methods (4 papers). Rakesh Narang collaborates with scholars based in India, United States and Saudi Arabia. Rakesh Narang's co-authors include Kalvatala Sudhakar, Sachin Kumar Singh, Monica Gulati, Surendra Kumar Nayak, Gopal L. Khatik, Vikramjeet Singh, Ashish Suttee, Manish Vyas, Surajpal Verma and Raj Kumar and has published in prestigious journals such as European Journal of Medicinal Chemistry, Current Medicinal Chemistry and Ageing Research Reviews.

In The Last Decade

Rakesh Narang

20 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rakesh Narang India 12 124 118 73 44 39 25 376
Ashish Wadhwani India 11 75 0.6× 131 1.1× 33 0.5× 18 0.4× 40 1.0× 30 391
Mohammed Faiz Arshad Saudi Arabia 8 129 1.0× 85 0.7× 34 0.5× 12 0.3× 22 0.6× 12 351
Kapendra Sahu India 11 180 1.5× 104 0.9× 49 0.7× 20 0.5× 54 1.4× 37 398
И. В. Сорокина Russia 14 165 1.3× 227 1.9× 67 0.9× 41 0.9× 45 1.2× 53 591
Iten M. Fawzy Egypt 12 155 1.3× 133 1.1× 31 0.4× 79 1.8× 67 1.7× 30 442
Grażyna Neunert Poland 12 84 0.7× 157 1.3× 41 0.6× 51 1.2× 23 0.6× 30 487
Graeme Kay United Kingdom 11 81 0.7× 69 0.6× 68 0.9× 31 0.7× 104 2.7× 18 439
Umasankar Kulandaivelu India 12 206 1.7× 151 1.3× 19 0.3× 14 0.3× 49 1.3× 63 459
Lixiang Ren China 10 130 1.0× 244 2.1× 243 3.3× 25 0.6× 55 1.4× 13 614
Heba Abdel‐Halim Jordan 11 44 0.4× 163 1.4× 20 0.3× 18 0.4× 42 1.1× 21 402

Countries citing papers authored by Rakesh Narang

Since Specialization
Citations

This map shows the geographic impact of Rakesh Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Narang more than expected).

Fields of papers citing papers by Rakesh Narang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakesh Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Narang. The network helps show where Rakesh Narang may publish in the future.

Co-authorship network of co-authors of Rakesh Narang

This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh Narang. A scholar is included among the top collaborators of Rakesh Narang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh Narang. Rakesh Narang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gupta, Pankaj, et al.. (2025). Recent developments of the β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors: Emerging indication as antibacterial agents. European Journal of Medicinal Chemistry. 298. 117995–117995. 1 indexed citations
4.
Pahwa, Rakesh, et al.. (2023). Recent Insights into Osimertinib Analogues against EGFR PositiveNon-small Cell Lung Cancer. Current Topics in Medicinal Chemistry. 23(21). 2001–2026.
5.
Kumar, Manish, et al.. (2023). In-Silico Design, Synthesis, and Pharmacological Evaluation of Oxadiazole-Based Selective Cyclo-oxygenase-2 Inhibitors. Assay and Drug Development Technologies. 21(4). 166–179. 2 indexed citations
6.
Yadav, Alka, Vikramjeet Singh, Manoj Kumar, et al.. (2023). Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs. Ageing Research Reviews. 88. 101960–101960. 55 indexed citations
7.
Narang, Rakesh, et al.. (2023). Quinoline Hydrazide/Hydrazone Derivatives: Recent Insights on Antibacterial Activity and Mechanism of Action. ChemMedChem. 18(5). e202200571–e202200571. 60 indexed citations
8.
Gupta, Pankaj, et al.. (2023). Recent insights into antibacterial potential of benzothiazole derivatives. Medicinal Chemistry Research. 32(8). 1543–1573. 22 indexed citations
9.
Narang, Rakesh, et al.. (2022). Thiazolopyrimidines: A Retrospective Study of Synthesis,Structure-Activity Relationship and Diverse Pharmacological Actions. Asian Journal of Chemistry. 34(3). 519–530. 1 indexed citations
10.
Pahwa, Rakesh, et al.. (2022). Melphalan: Recent insights on synthetic, analytical and medicinal aspects. European Journal of Medicinal Chemistry. 238. 114494–114494. 11 indexed citations
12.
Narang, Rakesh, et al.. (2021). MOLECULAR DOCKING STUDIES OF THIAZOLOPYRIMIDINE DERIVATIVES AS ANTIMICROBIAL AGENTS. Journal of Advanced Scientific Research. 12(03 Suppl 2). 285–291. 1 indexed citations
13.
Khokra, Sukhbir Lal, et al.. (2020). EX-VIVO: ANTHELMINTIC EVALUATION OF BOMBAX CEIBA STEM EXTRACTS. International Journal of Pharmaceutical Sciences and Drug Research. 431–436. 2 indexed citations
15.
Vyas, Manish, Surendra Kumar Nayak, Ashish Suttee, et al.. (2019). An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus. Current Diabetes Reviews. 16(2). 117–136. 56 indexed citations
16.
Narang, Rakesh, Raj Kumar, Sourav Kalra, et al.. (2019). Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent. European Journal of Medicinal Chemistry. 182. 111644–111644. 26 indexed citations
17.
Singh, Sachin Kumar, Bimlesh Kumar, Monica Gulati, et al.. (2019). A three-pronged formulation approach to improve oral bioavailability and therapeutic efficacy of two lipophilic drugs with gastric lability. Drug Delivery and Translational Research. 9(4). 848–865. 18 indexed citations
18.
Yadav, Ankit, Varun Garg, Monica Gulati, et al.. (2018). DESIGN AND PERFORMANCE VERIFICATION OF NEWLY DEVELOPED DISPOSABLE STATIC DIFFUSION CELL FOR DRUG DIFFUSION/PERMEABILITY STUDIES. Asian Journal of Pharmaceutical and Clinical Research. 11(14). 1–1. 2 indexed citations
19.
Pandey, Narendra Kumar, Varun Garg, Bimlesh Kumar, et al.. (2017). Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and Characterization. AAPS PharmSciTech. 18(7). 2454–2465. 13 indexed citations
20.
Kaur, Jasmine, Sachin Kumar Singh, Bimlesh Kumar, et al.. (2017). FORMULATION OF CURCUMIN NANOSUSPENSION USING BOX-BEHNKEN DESIGN AND STUDY OF IMPACT OF DRYING TECHNIQUES ON ITS POWDER CHARACTERISTICS. Asian Journal of Pharmaceutical and Clinical Research. 10(16). 43–43. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026